HZNP down 20% after FDA Approval# Stock
a*n
1 楼
According to the articles on Yahoo finance, it is due to heavy debt load and
marketing failure to generate revenue quickly. Another reason is potential
threat from generic drugs.
marketing failure to generate revenue quickly. Another reason is potential
threat from generic drugs.